Array BioPharma (ARRY)
Create an Alert
4.96
-0.13 -2.55%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Array BioPharma Cash from Investing Quarterly:
6.732M for March 31, 2013Array BioPharma Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 6.732M |
| Dec. 31, 2012 | -32.10M |
| Sept. 30, 2012 | 14.26M |
| June 30, 2012 | 2.628M |
| March 31, 2012 | -36.04M |
| Dec. 31, 2011 | 3.983M |
| Sept. 30, 2011 | 10.70M |
| June 30, 2011 | 21.29M |
| March 31, 2011 | 14.84M |
| Dec. 31, 2010 | 18.15M |
| Sept. 30, 2010 | 19.82M |
| June 30, 2010 | -78.88M |
| March 31, 2010 | 0.709M |
| Dec. 31, 2009 | 5.849M |
| Sept. 30, 2009 | 3.256M |
| June 30, 2009 | 0.434M |
| March 31, 2009 | 5.413M |
| Dec. 31, 2008 | 19.70M |
| Sept. 30, 2008 | 3.458M |
| June 30, 2008 | -21.24M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
ARRY Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Cytokinetics | 10.47M |
| Celldex Therapeutics | -46.58M |
| Oncothyreon | -2.677M |
ARRY Cash from Investing Quarterly Rankings
| Overall |
96th percentile 666 of 16773 |
| Sector |
95th percentile 68 of 1408 in Healthcare |
| Industry |
91st percentile 39 of 453 in Biotechnology |
ARRY Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -78.88M | Jun 2010 |
| Maximum | 21.29M | Jun 2011 |
| Average | -0.8513M |
